Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/2/2020
SIETES contiene 92902 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Mozley LH, Vandenberghe R, Mo Y, Michelson D. Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102593]
2.Enlace a cita original Cita con resumen
de Souto Barredo P, Lapeyre-Mestre M, Cefac P, Vellas B, Rolland Y. Effects of a geriatic intervention aiming to improve quality care in nursing home on benzodiazepine use and discontinuation. Br J Clin Pharmacol 2016;81:759-67. [Ref.ID 100180]
3.Enlace a cita original Cita con resumen
Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S, REAL.FR Group. Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!. Eur J Clin Pharmacol 2013;69:1589-97. [Ref.ID 95990]
4.Tiene citas relacionadas Cita con resumen
Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He FJ, Sun X, Thomas RG, Aisen PS, Siemers E, Sethuraman G, Nohs R, for the Alzheimer's Disease Cooperative Study Steering Committee on the Semagacestat Study Group. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 2013;369:341-50. [Ref.ID 95879]
5. Cita con resumen
Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues J-F, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S, for the GidAge Study Group. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012;11:851-9. [Ref.ID 92936]
6.
Rolland Y, van Kan GA, Bénétos A, Blain H, Bonnefoy M, Chassagne P, Jeandel C, Laroche M, Nourhashémi F, Orcel P, Piette F, Ribot C, Ritz P, Roux C, Taillandier J, Trémollières F, Weryha G, Vellas B. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. Nutr Health Aging 2008;12:1. [Ref.ID 83334]
7.
Amouyal-Barkate K, Bagheri-Charabiani H, Montastruc J-L, Moulias S, Vellas B. Abnormal movements with donezepil in Alzheimer disease. Ann Pharmacother 2000;34:1347. [Ref.ID 53855]
Seleccionar todas
 
 1 a 7 de 7